Related Experiment Video

Updated: Jan 24, 2026

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
05:42

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction

Published on: January 26, 2024

3.1K

Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer

Brandon M Roane1, Rebecca C Arend2, Michael J Birrer3

  • 1Department of Obstetrics and Gynecology-Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, USA. broane@uabmc.edu.

Cancers
|May 17, 2019
PubMed

Insights

Transforming Growth Factor-beta (TGF-β) signaling drives ovarian cancer progression and recurrence. Targeting this pathway offers a promising strategy to improve patient outcomes and survival rates.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ovarian cancer treatment has seen limited progress, with most patients experiencing recurrence despite initial therapy.
  • Identifying prognostic biomarkers and therapeutic targets is crucial for improving ovarian cancer patient survival.
  • Transforming Growth Factor-beta (TGF-β) is a protein superfamily involved in normal development and cancer progression.

Purpose of the Study:

  • To review the role of TGF-β in ovarian cancer progression.
  • To elucidate the mechanisms of TGF-β signaling in this malignancy.
  • To discuss targeted therapies directed at the TGF-β pathway for ovarian cancer treatment.

Main Methods:

  • Literature review of studies on TGF-β signaling in ovarian cancer.
  • Analysis of mechanisms linking TGF-β to tumor dissemination (immune evasion, angiogenesis, EMT).
  • Examination of current and emerging targeted therapies for the TGF-β pathway.

Main Results:

  • TGF-β hypersignaling promotes ovarian cancer progression by enhancing tumor dissemination.
  • Mechanisms include facilitating immune evasion, promoting angiogenesis, and driving epithelial-to-mesenchymal transition.
  • Targeted therapies against TGF-β are under investigation for clinical application.

Conclusions:

  • The TGF-β pathway is a significant driver of ovarian cancer progression and recurrence.
  • Targeting TGF-β represents a viable therapeutic strategy to improve treatment efficacy.
  • Further research into TGF-β biomarkers and targeted therapies is warranted for ovarian cancer patients.
Keywords:
TGF-βbiomarkersovarian cancerproliferationtransforming growth factor-β

More Related Videos

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

18.8K
In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells11:37

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells

Published on: February 18, 2015

14.2K

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.3K
Factors Influencing Microbial Growth: pH01:29

Factors Influencing Microbial Growth: pH

Microorganisms are classified as acidophiles, neutrophiles, or alkaliphiles based on their pH growth preferences, reflecting their adaptations to specific environments. Maintaining a stable intracellular pH is critical for macromolecular stability and enzymatic activity, which can be challenged by external pH variations.Neutrophiles, such as Escherichia coli, grow optimally between pH 5.5 and 8.0. These microorganisms inhabit neutral or slightly acidic environments and employ mechanisms like...
1.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Factors Influencing Microbial Growth: Temperature01:27

Factors Influencing Microbial Growth: Temperature

Microorganisms display remarkable adaptations, enabling them to thrive in diverse ecological niches across a wide range of temperatures. Temperature profoundly influences microbial growth by affecting enzymatic activity, membrane fluidity, and other cellular processes.Each microorganism operates within a specific temperature range defined by three cardinal points: minimum, optimum, and maximum. Below the minimum temperature, membranes lose fluidity, halting transport processes. Above the...
1.2K
Factors Influencing Microbial Growth: Osmolarity01:28

Factors Influencing Microbial Growth: Osmolarity

Osmolarity is the measure of solute concentration in a solution. It plays a critical role in determining water availability for organisms. Water moves across semipermeable membranes through osmosis, flowing from regions of lower solute concentration (more dilute) to regions of higher solute concentration (more concentrated).In high-solute environments, microbial cells lose water, leading to dehydration and inhibited growth. The extent to which water is available to microbes in such environments...
778
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
59.5K